http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001002421-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3cb50e711398b7ae2f0202e5f440ea9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf40acf8fe6f9ef5192312425fde34cb |
| publicationDate | 2001-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2001002421-A1 |
| titleOfInvention | Methods for in vitro susceptibility testing of chlamydia |
| abstract | Methods for determining the susceptibility of intracellular pathogens, particularly Chlamydia, to single or combination of test agents are described. The methods can be used for in vitro or in vivo evaluation of agents that can be used as therapeutic agents in the treatment/eradication of pathogen infection in general or to target a specific infected organ. Assays which utilize nucleic amplification techniques (e.g., PCR) to determine effectiveness of the agent(s) evaluated are also described. |
| priorityDate | 1997-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.